by Vandana Singh | Jan 15, 2026 | General
Ocugen, Inc. (NASDAQ:OCGN) on Thursday shared preliminary data from its phase 2 clinical trial for OCU410, a gene therapy targeting geographic atrophy. • Ocugen stock is taking a hit today. What’s weighing on OCGN shares? The stock’s decline comes as the broader...
by Piero Cingari | Jan 15, 2026 | General
U.S. stocks rallied near record territory on Thursday as blowout earnings from major Wall Street firms and renewed confidence in the AI trade lifted risk appetite. The Nasdaq 100 jumped 1.2%, on track to fully erase Wednesday’s losses, while the S&P 500...
by Parshwa Turakhiya | Jan 15, 2026 | General
XRP (CRYPTO: XRP) is testing $2.13 after four consecutive rejections at a key resistance line, but Ripple’s $150 million deal with LMAX Group and $1.26 billion in ETF inflows are setting up a potential breakout to $3. Four Rejections Mark The Resistance XRP has tried...
by Vandana Singh | Jan 15, 2026 | General
STAAR Surgical Company (NASDAQ:STAA) shares are down on Thursday as the company is undergoing significant board changes. Broadwood Partners Joins STAAR Surgical Board Neal Bradsher and Richard LeBuhn of Broadwood Partners, along with Christopher Wang of Yunqi Capital,...
by Anusuya Lahiri | Jan 15, 2026 | General
JPMorgan Chase & Co. (NYSE:JPM) is ramping up its defenses against fast-growing electronic trading rivals, forming a new quantitative trading and research group. New Quant Group Targets Electronic Trading Edge The bank has created a new quantitative trading and...
Recent Comments